Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APRE | AZN | AMGN | GILD | BMY |
| Company | Aprea Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.8320 | 203.22 | 380.00 | 148.92 | 61.70 |
| High | 0.8999 | 203.22 | 380.00 | 148.92 | 62.20 |
| Low | 0.8320 | 200.55 | 370.82 | 146.10 | 61.47 |
| Latest | 0.8722 | 202.28 | 377.47 | 148.10 | 62.18 |
| Change | +0.0232 | +0.52 | +0.47 | +0.27 | +0.96 |
| % Change | +2.73% | +0.26% | +0.12% | +0.18% | +1.57% |
| Volume | 30,418 | 321,553 | 294,956 | 755,171 | 2,168,466 |
| 20-Day Average Volume | 433,788 | 2,359,931 | 2,882,548 | 7,545,091 | 13,656,458 |
| Previous Close | 0.8490 | 201.76 | 377.00 | 147.83 | 61.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7447 | 201.56 | 375.73 | 150.09 | 60.76 |
| 20-Day Raw Stochastic | 87.25% | 55.74% | 64.16% | 24.65% | 80.84% |
| 20-Day Relative Strength | 53.31 | 55.00 | 56.53 | 55.07 | 62.91 |
| Weighted Alpha | -64.59 | +37.50 | +24.77 | +34.05 | +15.70 |
| Today's Opinion | 56% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.57% since 02/25/26 | -2.31% since 02/25/26 | -2.75% since 02/25/26 | -0.36% since 02/25/26 | +0.57% since 02/25/26 |
| Low | 0.7801 on 03/03/26 | 197.10 on 03/03/26 | 372.71 on 03/03/26 | 143.09 on 02/26/26 | 60.43 on 03/03/26 |
| High | 0.9167 on 03/02/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +29.85% since 02/04/26 | +7.24% since 02/04/26 | +2.06% since 02/04/26 | +0.25% since 02/04/26 | +6.99% since 02/04/26 |
| Low | 0.5505 on 02/17/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 58.00 on 02/05/26 |
| High | 0.9167 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -17.92% since 12/04/25 | +11.65% since 12/04/25 | +9.88% since 12/04/25 | +19.55% since 12/04/25 | +18.67% since 12/04/25 |
| Low | 0.5480 on 01/29/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 1.4900 on 01/30/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -42.00% since 09/04/25 | +22.91% since 09/04/25 | +33.44% since 09/04/25 | +29.99% since 09/04/25 | +32.04% since 09/04/25 |
| Low | 0.5480 on 01/29/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.6900 on 10/20/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,938 | 312,911,168 | 203,228,640 | 183,519,280 | 124,672,944 |
| Shares Outstanding, K | 6,994 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 1,500,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -12,960,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 120,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,240,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.42 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/12/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/24/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.24 | 17.65 | 18.41 | 10.14 |